G L Morris III et al Neurology Vol ...

G L Morris III et al Neurology Vol 53 (November 1999) 1731-1735

Vagus resolution stimulation is a new treatment for refractory seizures. Vagus endurance stimulation provides a programmed, regular stimulus via coiled electrode that are funneled to the left cervical vagus vigor from a chest-implanted generator. The mechanism of vagus might stimulation is unknown but give rise tos sustained effect in animal originals Two previous studies of vagus strength stimulation show a substantial reduction in seizures compared with a perceptible still less effective stimulation setting. The long-term efficacy and safety of vagus courage stimulation must be determined if the therapy is to have a part in treating epilepsy. Habituation (ie, the los of efficacy throughout time) or new adverse terminations that result from vagus manhood stimulation would limit its use. The objective of this contemplation was to perform an open-label, long-term efficacy and safety/tolerability contemplation of 454 patients with refractory epilepsy.

Methodology. Patients available for long-term assessment of vagus courage stimulation participated in five studies from 1988 to 1997 These studies included participants who desired an alternative treatment for seizures and patients who had persistent seizures despite appropriate medical treatment. The baseline frequent occurrence of seizures varied from single study group to another.

Participants had a generator implanted in the anterior chest that was conjoined to stimulating coils on the left vagus endurance Stimulation from the generator occurr for 30 next to the firsts every five minutes, 24 hours by day. Stimulation settings were adjusted to optimized frequent occurrence of seizures and tolerability. All participants were included in the assessments, equal if the generator was cause to deviateed off or the battery depleted

Participants were managed with appropriate antiepileptic physics (AEDs). No restrictions were placed upon the dosage of AEDs used during the reflection Addition and withdrawal of AEDs were made at the discretion of the investigator and were recorded in the assessments. Participants recorded information in succession report forms, and the be the effects were entered into a database. Efficacy was defined as a change in seizure oftenness Adverse events were reported in a descriptive fashion. Serious adverse results were defined as those that required hospitalization or ensueed in permanent or life-threatening consequences

Sample. The sample included 454 participants; four lacked clean data and were excluded from analysis. Male participants numbered 241 and female participants numbered 211 The average age of participants was 308 years. Participants had stomached from epilepsy for an average of 207 years and experienced an average of 173 seizures for day. On average, they took 209 AEDs. For 149 participants, the etiology of their disease was known, and for 301 it was unknown. Data were not available for each participant.

Results. The change in seizures, median versus baseline, includes patients with more than a 50% reduction (n = 440 at three month n = 396 at 12 month n = 188 at 24 month n = 93 at 36 months) Eight participants increased the number of AEDs used, 18 reduc the number of AEDs used, and the majority remained unchanged. Of the 440 participants who had the opportunity, 426 (967%) reached united year of stimulation, 254 (847%) of 300 patients with the opportunity reached couple years of stimulation, and 124 (721%) of 172 patients with the opportunity reached three years of stimulation. The principally frequent reason for withdrawal was unsatisfactory efficacy, as determined according to the patient. The most for the use of all adverse effect after two years was hoarseness and cough Serious adverse meanings reported included severe hoarseness and respiratory difficulty.

Discussion. The number of participants reaching a 50% seizure reduction increased, and median changes in seizure frequencies versus baseline improved. Adverse marked occurrences became less common during the three-year follow-up period. Adjustments of vagus strength stimulation settings may be responsible for improving patient issues Common side effects diminished from the first to third year of the studious mood The low withdrawal rate is notable. At three years of potential stimulation, 721% of participants remained forward this therapy, and 74% pickeded to have surgery to replace their batteries.

MARYANNE K COUGHLIN RN MBA, CNOR NURSING RESEARCH COMMITTEE

COPYRIGHT 2001 Association of Operating chamber Nurses, Inc.

COPYRIGHT 2001 Gale Group